Xencor, Inc.

NASDAQ:XNCR

Biotechnology

Healthcare
$34.01 -1.03%

-$0.13 today

Market cap
$2.55B
Beta
0.93
P/E (TTM)
-5.5
EPS (TTM)
-$2.29
52W Low $6.92High $18.69

Volume 1.09M

Average 0.80M

Returns on capital

Xencor, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-14.5%

avg -9.7%

ROIC

-21.5%

avg -10.0%

ROA

-10.5%

avg -7.2%

Analysis

ROA is currently the strongest return metric at -10.5% versus its period average of -7.2%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Bassil I. Dahiyat

Co-Founder, Chief Executive Officer, President & DirectorUSD 1.24M56546.32K0.74%

John R. Desjarlais

Executive Vice President of Research & Chief Scientific OfficerUSD 858.49K62263.83K0.36%

Bart Jan Cornelissen

Senior Vice President & Chief Financial OfficerUSD 816.11K4865.80K0.09%

Celia E. Eckert

Senior Vice President, General Counsel & Corporate SecretaryUSD 744.19K54——

Jeffrey Chou

Senior Vice President of Clinical Development- Oncology————

Mark Osterman

Senior Vice President of Clinical Development (Autoimmune)————

Eric Kowack

Senior Vice President of Program Leadership & Alliance Management————

Kirk Rosemark

Senior Vice President of Regulatory Affairs & Quality Assurance—61——

Jennifer Sandoz

Senior VIce President of Human Resources————

Dane Vincent Leone

Executive Vice President & Chief Strategy Officer————

Charles Liles

Associate Director and Head of Corporate Communications & Investor Relations————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Nov 11, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

0

$0.00

Sells

21

$7.49M

Net Transaction Value

−$7.49M

Net selling

Most Active

Desjarlais John R

4 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Nov 11, 26

Cornelissen Bart Jan

Direct

Sell$402.2K
Nov 10, 26

RANIERI RICHARD J

Direct

Sell$2.7M
Nov 10, 26

RANIERI RICHARD J

Direct

Sell$442.3K
Jun 18, 26

Feigal Ellen

Direct

Sell$89.4K
Jun 15, 26

Montgomery Alan Bruce

Direct

Sell$62.3K
Jun 15, 26

GORMAN KEVIN CHARLES

Direct

Sell$92.7K
Jun 15, 26

GUSTAFSON KURT A

Direct

Sell$67.4K
Jun 15, 26

RANIERI RICHARD J

Direct

Sell$67.4K
Apr 10, 26

Cornelissen Bart Jan

Direct

Sell$43K
Mar 6, 26

Desjarlais John R

Direct

Sell$27.6K

1–10 of 21

Summary

Insiders reported 0 buys worth $0.00 and 21 sells worth $7.49M over the last 12 months. That adds up to net selling of $7.49M. Desjarlais John R was the most active insider with 4 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A4 analysts
RevenueN/AN/A-8.6%
+28.1% (5yr)5 analysts
Net IncomeN/AN/AN/A
N/A5 analysts
EBITN/AN/AN/A
N/A5 analysts

Analysis

Recent growth has been strongest in Revenue at -8.6% over three years. Forward estimates point to Revenue at +28.1% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Xencor, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about XNCR's management, answered from reported figures.

Who manages XNCR?

Xencor, Inc. (XNCR) lists 11 active executives. The top listed executive is Bassil I. Dahiyat, Co-Founder, Chief Executive Officer, President & Director.

Are XNCR insiders buying or selling?

Recent insider activity shows net buying of $31.46M.